PROPIMMUN Trademark

Trademark Overview

On Monday, November 2, 2015, a trademark application was filed for PROPIMMUN with the United States Patent and Trademark Office. The USPTO has given the PROPIMMUN trademark a serial number of 79178924. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 12, 2023. This trademark is owned by FLEXOPHARM GmbH & Co. KG. The PROPIMMUN trademark is filed in the Pharmaceutical Products category with the following description:

Nutritional supplements; *, namely, propionic acid and propionic acid derivatives, in particular propionates; * medicines for treatment of intestinal, metabolic, cardiovascular and autoimmunological disorders *, namely, propionic acid and propionic acid derivatives, in particular propionates *
propimmun

General Information

Serial Number79178924
Word MarkPROPIMMUN
Filing DateMonday, November 2, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, May 12, 2023
Registration Number5070644
Registration DateTuesday, November 1, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 16, 2016

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 5, after supplements, " , namely propionic acid and propionic acid derivatives, in particular propionates;" should be inserted. In the statement, after line 6, " namely propionic acid and propionic acid derivatives, in particular propionates " should be inserted.
Goods and ServicesNutritional supplements; *, namely, propionic acid and propionic acid derivatives, in particular propionates; * medicines for treatment of intestinal, metabolic, cardiovascular and autoimmunological disorders *, namely, propionic acid and propionic acid derivatives, in particular propionates *

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFLEXOPHARM BRAIN GmbH & Co. KG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressDE
Party NameFLEXOPHARM GmbH & Co. KG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameFLEXOPHARM GmbH & Co. KG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameFLEXOPHARM GmbH & Co. KG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Sunday, February 18, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, January 25, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, January 25, 2024INVALIDATION PROCESSED
Friday, January 12, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 12, 2023CANCELLED SECTION 71
Monday, November 1, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, February 5, 2021ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, May 16, 2018INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Saturday, May 12, 2018PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 5, 2018NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 15, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, September 12, 2017CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, September 12, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 7, 2017CHANGE OF OWNER RECEIVED FROM IB
Thursday, July 20, 2017LIMITATION OF GOODS RECEIVED FROM IB
Friday, June 23, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 6, 2017FINAL DISPOSITION NOTICE SENT TO IB
Monday, March 6, 2017FINAL DISPOSITION PROCESSED
Wednesday, February 1, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, November 11, 2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, November 1, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, August 16, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 16, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 27, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 27, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 11, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, July 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 2, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 2, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 30, 2016ASSIGNED TO LIE
Monday, June 27, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 18, 2016REFUSAL PROCESSED BY IB
Monday, February 29, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, February 29, 2016REFUSAL PROCESSED BY MPU
Saturday, February 27, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 26, 2016NON-FINAL ACTION WRITTEN
Wednesday, February 24, 2016ASSIGNED TO EXAMINER
Friday, January 1, 2016APPLICATION FILING RECEIPT MAILED
Monday, December 28, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 17, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

propimmun acid propionic particular derivatives propionates namely cardiovascular autoimmunological disorders metabolic